|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2005-11-30
|
|
pubmed:abstractText |
There is strong evidence that genetic factors contribute to the susceptibility for inflammatory bowel diseases (IBD). Recently, IL-18 promoter polymorphisms were characterized as risk factors for inflammatory diseases such as sepsis, asthma and adult-onset Still's disease. The aim of this study was to determine whether the -137 (G/C) IL-18 promoter polymorphism was associated with IBD susceptibility.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1438-43
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:16316892-Adult,
pubmed-meshheading:16316892-Case-Control Studies,
pubmed-meshheading:16316892-Child,
pubmed-meshheading:16316892-Colitis, Ulcerative,
pubmed-meshheading:16316892-Crohn Disease,
pubmed-meshheading:16316892-Female,
pubmed-meshheading:16316892-Genotype,
pubmed-meshheading:16316892-Germany,
pubmed-meshheading:16316892-Humans,
pubmed-meshheading:16316892-Interleukin-18,
pubmed-meshheading:16316892-Male,
pubmed-meshheading:16316892-Polymorphism, Genetic,
pubmed-meshheading:16316892-Promoter Regions, Genetic
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
-137 (G/C) IL-18 promoter polymorphism in patients with inflammatory bowel disease.
|
|
pubmed:affiliation |
Department of Medicine II, Medical Faculty at Mannheim, University of Heidelberg, Mannheim, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
